| |
Axel Bolte
Investment Advisor, HBM Partners
Paul Chaney
Independent
Thomas Dyrberg, M.D., Ph.D.
Partner, Novo A/S
Lutz Giebel, Ph.D.
Managing Partner, SV Life Sciences
David R. Guyer, M.D.
Partner, SV Life Sciences
David Schnell, M.D.
Managing Director, Prospect Venture Partners
Dean J. Mitchell
President & Chief Executive Officer
© 2009 Lux
Biosciences, Inc. All rights reserved.
Web
Terms
Clinical
Trials
|
